Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 196 participants.

Also called NCT03664414

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 196 participants (planned count) (from the registry)
Sponsor
Maria Eugenia Galván Plata (from the registry)
Registry
  • NCT NCT03664414
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Mexico (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03664414. Randomized; double masking; primary purpose treatment. Start 2018-03-01 (actual); primary completion 2019-07-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY)
Acronym
PENFOSIDINE
Condition
Chronic Kidney Disease stage3 and 4
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
pentoxifylline
Lead sponsor
Maria Eugenia Galván Plata (class: other government)
Collaborator
Centro de Investigación Biomédica de Michoacán. (class: not stated)
Collaborator
Hospital General Regional N° 1 Instituto Mexicano del Seguro Social. (class: not stated)
Collaborator
Hospital General de Zona N° 83 Instituto Mexicano del Seguro Social. (class: not stated)
Collaborator
Coordinación Auxiliar Medica de Investigación en Salud. Delegación Michoacán. (class: not stated)

Record details

Record id
cardio:ct-nct03664414
Content hash
06df214253c7e3ba75bab392c8836b5a1a74feaa2663290a8f90018251e60275